These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 39354876

  • 21. [Usefulness of the determination of IgG and IgM antibodies by ELISA and immunocapture in a clinical series of human brucellosis].
    Aranís J C, Oporto C J, Espinoza M, Riedel K I, Pérez C C, García C P.
    Rev Chilena Infectol; 2008 Apr; 25(2):116-21. PubMed ID: 18483644
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Assessment of index value performance of enzyme immunoassay test in predicting the diagnosis of human brucellosis.
    Bakir A, Mustafa M, Alacam S, Sig AK, Bekiroglu N, Yavuz MT.
    J Infect Dev Ctries; 2022 May 30; 16(5):807-812. PubMed ID: 35656951
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of serological tests for diagnosis of brucellosis.
    Pabuccuoglu O, Ecemis T, El S, Coskun A, Akcali S, Sanlidag T.
    Jpn J Infect Dis; 2011 May 30; 64(4):272-6. PubMed ID: 21788700
    [Abstract] [Full Text] [Related]

  • 26. Comparison of a dipstick assay for detection of Brucella-specific immunoglobulin M antibodies with other tests for serodiagnosis of human brucellosis.
    Clavijo E, Díaz R, Anguita A, García A, Pinedo A, Smits HL.
    Clin Diagn Lab Immunol; 2003 Jul 30; 10(4):612-5. PubMed ID: 12853393
    [Abstract] [Full Text] [Related]

  • 27. Limited diagnostic usefulness of antibodies to cytoplasmic proteins of Brucella in early-treated human brucellosis.
    Baldi PC, Giambartolomei GH, Wallach JC, Velikovsky CA, Fossati CA.
    Scand J Infect Dis; 2001 Jul 30; 33(3):200-5. PubMed ID: 11303810
    [Abstract] [Full Text] [Related]

  • 28. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
    Kang K, Huang L, Ouyang C, Du J, Yang B, Chi Y, He S, Ying L, Chen G, Wang J.
    J Med Virol; 2021 May 30; 93(5):2838-2847. PubMed ID: 33231312
    [Abstract] [Full Text] [Related]

  • 29. Detection of IgM antibrucella antibody in the absence of IgGs: a challenge for the clinical interpretation of brucella serology.
    Solís García Del Pozo J, Lorente Ortuño S, Navarro E, Solera J.
    PLoS Negl Trop Dis; 2014 Dec 30; 8(12):e3390. PubMed ID: 25474572
    [Abstract] [Full Text] [Related]

  • 30. Rapid diagnosis of central nervous system brucellosis by ELISA.
    Araj GF, Lulu AR, Saadah MA, Mousa AM, Strannegard IL, Shakir RA.
    J Neuroimmunol; 1986 Sep 30; 12(3):173-82. PubMed ID: 3734058
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of in-house and commercial immunoassays for the sero-diagnosis of brucellosis in a non-endemic low prevalence population.
    Sharma R, Chisnall C, Cooke RP.
    J Infect; 2008 Feb 30; 56(2):108-13. PubMed ID: 18096236
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia.
    Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO.
    Diagn Microbiol Infect Dis; 2002 Oct 30; 44(2):129-32. PubMed ID: 12458117
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of a Brucella enzyme immunoassay test (ELISA) in comparison with bacteriological culture and agglutination.
    Gad El-Rab MO, Kambal AM.
    J Infect; 1998 Mar 30; 36(2):197-201. PubMed ID: 9570654
    [Abstract] [Full Text] [Related]

  • 34. A comparison of immuncapture agglutination and ELISA methods in serological diagnosis of brucellosis.
    Özdemir M, Feyzioğlu B, Kurtoğlu MG, Doğan M, Dağı HT, Yüksekkaya Ş, Keşli R, Baysal B.
    Int J Med Sci; 2011 Mar 30; 8(5):428-32. PubMed ID: 21814476
    [Abstract] [Full Text] [Related]

  • 35. [Diagnosis of human brucellosis. Role of pH in the seroagglutination test and influence of pH on the agglutinating activity of IgM, IgG and IgA antibodies].
    Rubio Vallejo M, del Pozo JL, Hernández-Molina JM, Dorronsoro Ibero I, Marrodán Ciordia T, Díaz García R.
    Enferm Infecc Microbiol Clin; 2002 Apr 30; 20(4):144-9. PubMed ID: 11996698
    [Abstract] [Full Text] [Related]

  • 36. Improved Early Detection of Focal Brucellosis Complications with Anti-Brucella IgG.
    Xu N, Dong X, Yao Y, Guan Y, Chen F, Zheng F, Wang G.
    J Clin Microbiol; 2020 Sep 22; 58(10):. PubMed ID: 32817225
    [Abstract] [Full Text] [Related]

  • 37. A time-resolved fluorescence lateral flow immunoassay for rapid and quantitative serodiagnosis of Brucella infection in humans.
    Lu J, Wu Z, Liu B, Wang C, Wang Q, Zhang L, Wang Z, Chen C, Fu Y, Li C, Li T.
    J Pharm Biomed Anal; 2021 Jun 05; 200():114071. PubMed ID: 33866295
    [Abstract] [Full Text] [Related]

  • 38. A modified indirect fluorescent antibody test for the diagnosis of brucellosis.
    Dhar R, Lastimoza JL, Hira PR.
    Diagn Microbiol Infect Dis; 1988 Dec 05; 11(4):189-94. PubMed ID: 3071447
    [Abstract] [Full Text] [Related]

  • 39. Diagnosis of human brucellosis with ELISA.
    Sippel JE, El-Masry NA, Farid Z.
    Lancet; 1982 Jul 03; 2(8288):19-21. PubMed ID: 6123753
    [Abstract] [Full Text] [Related]

  • 40. Development of a lateral flow immunochromatographic assay for rapid detection of Mycoplasma pneumoniae-specific IgM in human serum specimens.
    Ou L, Lv Q, Wu C, Hao H, Zheng Y, Jiang Y.
    J Microbiol Methods; 2016 May 03; 124():35-40. PubMed ID: 26979644
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.